Showing results (11-20 of 110) with videos related to
Sort By:
Pageof 11
Journal of Pharmaceutical Sciences|February 22, 2019
A "Dual" Cell-Level Systems PK-PD Model to Characterize the Bystander Effect of ADCAman P Singh, Dhaval K ShahJournal of Pharmacokinetics and Pharmacodynamics|November 25, 2010
Physiologically based pharmacokinetic model for topotecan in miceDhaval K Shah, Joseph P BalthasarJournal of Pharmacokinetics and Pharmacodynamics|May 5, 2025
A translational physiologically-based pharmacokinetic model for MMAE-based antibody-drug conjugatesHsuan-Ping Chang, Dhaval K ShahMethods in Molecular Biology (Clifton, N.J.)|October 24, 2019
Determination of ADC Concentration by Ligand-Binding AssaysHsuan-Ping Chang, Dhaval K ShahMabs|February 15, 2013
Antibody biodistribution coefficients: inferring tissue concentrations of monoclonal antibodies based on the plasma concentrations in several preclinical species and humanDhaval K Shah, Alison M BettsJournal of Pharmacokinetics and Pharmacodynamics|December 26, 2013
Predicting the effects of 8C2, a monoclonal anti-topotecan antibody, on plasma and tissue disposition of topotecanDhaval K Shah, Joseph P BalthasarThe AAPS Journal|April 5, 2017
Application of a PK-PD Modeling and Simulation-Based Strategy for Clinical Translation of Antibody-Drug Conjugates: a Case Study with Trastuzumab Emtansine (T-DM1)Aman P Singh, Dhaval K ShahJournal of Pharmacokinetics and Pharmacodynamics|December 7, 2011
Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and humanDhaval K Shah, Alison M BettsInternational Journal of Pharmaceutics|February 11, 2014
PK/TD modeling for prediction of the effects of 8C2, an anti-topotecan mAb, on topotecan-induced toxicity in miceDhaval K Shah, Joseph P BalthasarBioanalysis|July 31, 2015
Integration of bioanalytical measurements using PK-PD modeling and simulation: implications for antibody-drug conjugate developmentAntari Khot, Sharad Sharma, Dhaval K ShahPageof 11